146 related articles for article (PubMed ID: 10049592)
1. A physical map of the mouse shaker-2 region contains many of the genes commonly deleted in Smith-Magenis syndrome (del17p11.2p11.2).
Probst FJ; Chen KS; Zhao Q; Wang A; Friedman TB; Lupski JR; Camper SA
Genomics; 1999 Feb; 55(3):348-52. PubMed ID: 10049592
[TBL] [Abstract][Full Text] [Related]
2. Genomic organisation of the approximately 1.5 Mb Smith-Magenis syndrome critical interval: transcription map, genomic contig, and candidate gene analysis.
Lucas RE; Vlangos CN; Das P; Patel PI; Elsea SH
Eur J Hum Genet; 2001 Dec; 9(12):892-902. PubMed ID: 11840190
[TBL] [Abstract][Full Text] [Related]
3. Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome.
Yan J; Keener VW; Bi W; Walz K; Bradley A; Justice MJ; Lupski JR
Hum Mol Genet; 2004 Nov; 13(21):2613-24. PubMed ID: 15459175
[TBL] [Abstract][Full Text] [Related]
4. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome.
Chen KS; Manian P; Koeuth T; Potocki L; Zhao Q; Chinault AC; Lee CC; Lupski JR
Nat Genet; 1997 Oct; 17(2):154-63. PubMed ID: 9326934
[TBL] [Abstract][Full Text] [Related]
5. Mosaicism for del(17)(p11.2p11.2) underlying the Smith-Magenis syndrome.
Juyal RC; Kuwano A; Kondo I; Zara F; Baldini A; Patel PI
Am J Med Genet; 1996 Dec; 66(2):193-6. PubMed ID: 8958329
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations of MYO15A associated with profound deafness in consanguineous families and moderately severe hearing loss in a patient with Smith-Magenis syndrome.
Liburd N; Ghosh M; Riazuddin S; Naz S; Khan S; Ahmed Z; Riazuddin S; Liang Y; Menon PS; Smith T; Smith AC; Chen KS; Lupski JR; Wilcox ER; Potocki L; Friedman TB
Hum Genet; 2001 Nov; 109(5):535-41. PubMed ID: 11735029
[TBL] [Abstract][Full Text] [Related]
7. Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2).
Walz K; Spencer C; Kaasik K; Lee CC; Lupski JR; Paylor R
Hum Mol Genet; 2004 Feb; 13(4):367-78. PubMed ID: 14709593
[TBL] [Abstract][Full Text] [Related]
8. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb.
Schoumans J; Staaf J; Jönsson G; Rantala J; Zimmer KS; Borg A; Nordenskjöld M; Anderlid BM
Eur J Med Genet; 2005; 48(3):290-300. PubMed ID: 16179224
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion.
Potocki L; Chen KS; Park SS; Osterholm DE; Withers MA; Kimonis V; Summers AM; Meschino WS; Anyane-Yeboa K; Kashork CD; Shaffer LG; Lupski JR
Nat Genet; 2000 Jan; 24(1):84-7. PubMed ID: 10615134
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of a genetically unstable region containing the SMS critical area and a breakpoint cluster for human PNETs.
Wilgenbus KK; Seranski P; Brown A; Leuchs B; Mincheva A; Lichter P; Poustka A
Genomics; 1997 May; 42(1):1-10. PubMed ID: 9177769
[TBL] [Abstract][Full Text] [Related]
11. Fine-scale comparative mapping of the human 7q11.23 region and the orthologous region on mouse chromosome 5G: the low-copy repeats that flank the Williams-Beuren syndrome deletion arose at breakpoint sites of an evolutionary inversion(s).
Valero MC; de Luis O; Cruces J; Pérez Jurado LA
Genomics; 2000 Oct; 69(1):1-13. PubMed ID: 11013070
[TBL] [Abstract][Full Text] [Related]
12. Hemizygosity for the COP9 signalosome subunit gene, SGN3, in the Smith-Magenis syndrome.
Elsea SH; Mykytyn K; Ferrell K; Coulter KL; Das P; Dubiel W; Patel PI; Metherall JE
Am J Med Genet; 1999 Dec; 87(4):342-8. PubMed ID: 10588842
[TBL] [Abstract][Full Text] [Related]
13. Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).
Smith AC; Dykens E; Greenberg F
Am J Med Genet; 1998 Mar; 81(2):186-91. PubMed ID: 9613860
[TBL] [Abstract][Full Text] [Related]
14. Transcription mapping in a medulloblastoma breakpoint interval and Smith-Magenis syndrome candidate region: identification of 53 transcriptional units and new candidate genes.
Seranski P; Heiss NS; Dhorne-Pollet S; Radelof U; Korn B; Hennig S; Backes E; Schmidt S; Wiemann S; Schwarz CE; Lehrach H; Poustka A
Genomics; 1999 Feb; 56(1):1-11. PubMed ID: 10036180
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of risperidone treatment in Smith-Magenis syndrome (del 17 pll. 2).
Niederhofer H
Psychiatr Danub; 2007 Sep; 19(3):189-92. PubMed ID: 17914318
[TBL] [Abstract][Full Text] [Related]
16. Cloning, genomic structure, and expression of mouse ring finger protein gene Znf179.
Zhao Q; Chen KS; Bejjani BA; Lupski JR
Genomics; 1998 May; 49(3):394-400. PubMed ID: 9615224
[TBL] [Abstract][Full Text] [Related]
17. Subunit 3 of the COP9 signal transduction complex is conserved from plants to humans and maps within the smith-magenis syndrome critical region in 17p11.2.
Potocki L; Chen KS; Lupski JR
Genomics; 1999 Apr; 57(1):180-2. PubMed ID: 10191102
[No Abstract] [Full Text] [Related]
18. 17p11.2p12 triplication and del(17)q11.2q12 in a severely affected child with dup(17)p11.2p12 syndrome.
Girirajan S; Williams S; Garbern J; Nowak N; Hatchwell E; Elsea S
Clin Genet; 2007 Jul; 72(1):47-58. PubMed ID: 17594399
[TBL] [Abstract][Full Text] [Related]
19. Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse.
Bi W; Yan J; Stankiewicz P; Park SS; Walz K; Boerkoel CF; Potocki L; Shaffer LG; Devriendt K; Nowaczyk MJ; Inoue K; Lupski JR
Genome Res; 2002 May; 12(5):713-28. PubMed ID: 11997338
[TBL] [Abstract][Full Text] [Related]
20. Mood disorder in a patient with Smith-Magenis syndrome: a case report.
Bersani G; Russo D; Limpido L; Marconi D
Neuro Endocrinol Lett; 2007 Feb; 28(1):7-10. PubMed ID: 17277733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
